Form 4: Guardant Health Director Converts RSUs to Common Stock

Guardant Health Director Steve Krognes converted 154 restricted stock units into common stock on February 28, 2026.

Summary

• Steve E. Krognes, a Director at Guardant Health, Inc. (GH), reported a transaction on February 28, 2026.
• Krognes acquired 154 shares of Guardant Health Common Stock through the exercise or conversion of derivative securities (Restricted Stock Units) at a price of $0 per share.
• Following this transaction, Krognes directly beneficially owns 19,053 shares of Common Stock.
• Krognes also directly beneficially owns 618 Restricted Stock Units.
• The acquired shares are part of a Restricted Stock Unit award granted on August 9, 2022, which vested 25% on June 30, 2023.
• The remaining 75% of the RSU award vests in substantially equal monthly installments on each monthly anniversary of June 30, 2023, over a three-year period thereafter.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive event, as it represents a routine vesting of equity compensation for a director, increasing their direct ownership in the company and aligning their interests with shareholders.

Positives

• Director Steve Krognes increased his direct beneficial ownership of Guardant Health common stock by 154 shares, indicating continued alignment with shareholder interests.
• The transaction was a conversion of Restricted Stock Units, a common form of equity compensation, rather than an open market purchase, reflecting the vesting schedule of a previously granted award.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into how company executives and directors manage their equity holdings. This specific filing reflects a routine vesting and conversion of restricted stock units, a common component of executive compensation packages designed to align management incentives with long-term company performance.

Stakeholder Impact

• Shareholders may view the director's increased direct ownership as a positive sign of continued commitment to the company's long-term success.

Next Steps

• The remaining 618 Restricted Stock Units will continue to vest in substantially equal monthly installments on each monthly anniversary of June 30, 2023, over the three-year period thereafter.

Key Dates

Recommendation

This Form 4 reports a routine vesting and conversion of restricted stock units by a director, which is a standard part of executive compensation. The transaction itself, involving a relatively small number of shares, does not provide new fundamental information that would warrant a change in investment recommendation. It primarily reflects an increase in insider ownership, which is generally a neutral to slightly positive signal, supporting a 'hold' stance for existing investors.

Keywords

Guardant Health, GH, Form 4, Insider Transaction, RSU Conversion, Stock Acquisition, Steve Krognes